12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Company News  |  Deals

On-Q-ity, LabCorp deal

LabCorp received worldwide marketing rights to On-Q-ity's circulating tumor cell (CTC) platform. The platform includes...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >